Back to Treatments

Treatment

Naltrexone (Extended-Release Injectable)

1
Conditions
16
Trials
10K
Participants
68%
Average Safety

Condition Evidence

Opioid use disorders

16 trials · 10K participants

80% effectiveness · 68% safety
Naltrexone (Extended-Release Injectable) | DFDA